• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染六个月后康复者的肺功能测试评估

Assessment of Pulmonary Function Tests in COVID-19 Convalescents Six Months after Infection.

作者信息

Guziejko Katarzyna, Moniuszko-Malinowska Anna, Czupryna Piotr, Dubatówka Marlena, Łapińska Magda, Raczkowski Andrzej, Sowa Paweł, Kiszkiel Łukasz, Minarowski Łukasz, Moniuszko Marcin, Groth Monika, Kaminski Karol A

机构信息

2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland.

Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland.

出版信息

J Clin Med. 2022 Nov 29;11(23):7052. doi: 10.3390/jcm11237052.

DOI:10.3390/jcm11237052
PMID:36498626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9737969/
Abstract

Background: The aim of the study was to investigate the impact of COVID-19 on the pulmonary function tests (PFT) in COVID-19 convalescents six months after recovery. Additionally, the research question was whether PFT should be performed routinely in post-COVID-19 patients. Methods: A total of 39 patients with a history of COVID-19 6 months prior to the study were included in the study (Group I). Individuals were hospitalized or treated in the outpatients department. The control group (Group II) consisted of 39 healthy patients without a COVID-19 history. Each subject completed a questionnaire interview and underwent laboratory and pulmonary function examinations. Results: Six months after COVID-19 recovery, patients mainly complained about cough (46%, n = 18), shortness of breath (23%, n = 9), weakness (13%, n = 5), and memory/concentration disorders (8%, n = 3). In the group of patients complaining of persistent cough present 6 months after COVID-19, the following PFT parameters were decreased: FEV1, FVC, FRC, TLC, and DLCO (p < 0.05) in comparison with patients without this symptom. Conclusions: Persistent shortness of breath is not necessarily associated with pulmonary function impairment in patients 6 months after SARS-CoV-2 infection, and hence it requires appropriate differential diagnosis. Patients with a cough persisting 6 months after the acute phase of COVID-19 may benefit from PFT.

摘要

背景

本研究的目的是调查新冠病毒感染康复六个月后,新冠病毒病(COVID-19)对康复者肺功能测试(PFT)的影响。此外,研究问题是COVID-19康复后的患者是否应常规进行肺功能测试。方法:本研究纳入了39例在研究前6个月有COVID-19病史的患者(第一组)。这些个体曾住院治疗或在门诊接受治疗。对照组(第二组)由39例无COVID-19病史的健康患者组成。每位受试者均完成了问卷调查,并接受了实验室检查和肺功能检查。结果:COVID-19康复六个月后,患者主要抱怨咳嗽(46%,n = 18)、气短(23%,n = 9)、乏力(13%,n = 5)以及记忆/注意力障碍(8%,n = 3)。在COVID-19六个月后仍有持续性咳嗽的患者组中,与无此症状的患者相比,以下肺功能测试参数降低:第一秒用力呼气容积(FEV1)、用力肺活量(FVC)、功能残气量(FRC)、肺总量(TLC)和一氧化碳弥散量(DLCO)(p < 0.05)。结论:SARS-CoV-2感染六个月后的患者,持续性气短不一定与肺功能损害相关,因此需要进行适当的鉴别诊断。COVID-19急性期六个月后仍有咳嗽的患者可能会从肺功能测试中受益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbee/9737969/c5839e4acbb2/jcm-11-07052-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbee/9737969/43dbdd3a8990/jcm-11-07052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbee/9737969/c5839e4acbb2/jcm-11-07052-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbee/9737969/43dbdd3a8990/jcm-11-07052-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbee/9737969/c5839e4acbb2/jcm-11-07052-g002.jpg

相似文献

1
Assessment of Pulmonary Function Tests in COVID-19 Convalescents Six Months after Infection.新冠病毒感染六个月后康复者的肺功能测试评估
J Clin Med. 2022 Nov 29;11(23):7052. doi: 10.3390/jcm11237052.
2
Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study.新冠病毒感染后一年肺功能损害的纵向分析:一项单中心研究
J Pers Med. 2023 Jul 26;13(8):1190. doi: 10.3390/jpm13081190.
3
Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial.特瑞米德在 COVID-19 肺炎患者康复中的疗效和安全性:一项 2 期、随机、双盲、安慰剂对照试验。
J Transl Med. 2022 Nov 3;20(1):506. doi: 10.1186/s12967-022-03660-9.
4
COVID-19 and the effects on pulmonary function following infection: A retrospective analysis.新型冠状病毒肺炎及其感染后对肺功能的影响:一项回顾性分析。
EClinicalMedicine. 2021 Sep;39:101079. doi: 10.1016/j.eclinm.2021.101079. Epub 2021 Aug 13.
5
An assessment of post-COVID-19 infection pulmonary functions in healthcare professionals.新冠病毒感染后医护人员的肺功能评估。
Am J Infect Control. 2022 Oct;50(10):1125-1132. doi: 10.1016/j.ajic.2022.07.003. Epub 2022 Jul 20.
6
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
7
Impact of Symptomatology, Clinical and Radiological Severity of COVID-19 on Pulmonary Function Test Results and Functional Capacity during Follow-Up among Survivors.COVID-19的症状学、临床及影像学严重程度对幸存者随访期间肺功能测试结果及功能能力的影响
J Clin Med. 2023 Dec 21;13(1):45. doi: 10.3390/jcm13010045.
8
Pulmonary sequelae of SARS-CoV-2 infection and factors associated with persistent abnormal lung function at six months after infection: Prospective cohort study.新型冠状病毒感染的肺部后遗症及感染后 6 个月持续肺功能异常的相关因素:前瞻性队列研究。
PLoS One. 2022 Nov 17;17(11):e0277624. doi: 10.1371/journal.pone.0277624. eCollection 2022.
9
Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity.根据疾病严重程度,新冠病毒感染后无症状和持续有症状患者在 4 个月时的肺功能损伤。
Infection. 2022 Feb;50(1):157-168. doi: 10.1007/s15010-021-01669-8. Epub 2021 Jul 28.
10
Post-discharge chest CT findings and pulmonary function tests in severe COVID-19 patients.重症新型冠状病毒肺炎患者出院后的胸部CT表现及肺功能测试
Eur J Radiol. 2021 May;138:109676. doi: 10.1016/j.ejrad.2021.109676. Epub 2021 Mar 20.

引用本文的文献

1
Assessing the global burden of interstitial lung disease and pulmonary sarcoidosis using multiple statistical models: analysis and future projections.使用多种统计模型评估间质性肺疾病和肺结节病的全球负担:分析与未来预测
BMC Pulm Med. 2025 Jul 24;25(1):352. doi: 10.1186/s12890-025-03813-8.
2
Assessment of the Abnormalities in Chest Computed Tomography and Pulmonary Function Test in Convalescents Six Months After COVID-19.新型冠状病毒肺炎康复者六个月后胸部计算机断层扫描及肺功能测试异常情况评估
Medicina (Kaunas). 2025 Apr 29;61(5):823. doi: 10.3390/medicina61050823.
3
Clinical characteristics and effects of inhaled corticosteroid in patients with post-COVID-19 chronic cough during the Omicron variant outbreak.

本文引用的文献

1
Chest CT-based Assessment of 1-year Outcomes after Moderate COVID-19 Pneumonia.基于胸部 CT 的中度 COVID-19 肺炎 1 年后结局评估。
Radiology. 2022 Nov;305(2):479-485. doi: 10.1148/radiol.220019. Epub 2022 May 10.
2
The Investigation of Pulmonary Function Changes of COVID-19 Patients in Three Months.COVID-19 患者三个月肺功能变化研究。
J Healthc Eng. 2022 Jan 17;2022:9028835. doi: 10.1155/2022/9028835. eCollection 2022.
3
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months.
奥密克戎变异株流行期间,新冠病毒感染后慢性咳嗽患者吸入皮质类固醇的临床特征和效果。
BMC Pulm Med. 2024 Mar 27;24(1):156. doi: 10.1186/s12890-024-02937-7.
4
Pulmonary function 3-6 months after acute COVID-19: A systematic review and multicentre cohort study.急性新冠病毒感染后3至6个月的肺功能:一项系统评价和多中心队列研究
Heliyon. 2024 Mar 13;10(6):e27964. doi: 10.1016/j.heliyon.2024.e27964. eCollection 2024 Mar 30.
5
Evaluating Serum Calcium and Magnesium Levels as Predictive Biomarkers for Tuberculosis and COVID-19 Severity: A Romanian Prospective Study.评估血清钙和镁水平作为结核病和 COVID-19 严重程度的预测生物标志物:罗马尼亚的一项前瞻性研究。
Int J Mol Sci. 2023 Dec 28;25(1):418. doi: 10.3390/ijms25010418.
6
Impact of Symptomatology, Clinical and Radiological Severity of COVID-19 on Pulmonary Function Test Results and Functional Capacity during Follow-Up among Survivors.COVID-19的症状学、临床及影像学严重程度对幸存者随访期间肺功能测试结果及功能能力的影响
J Clin Med. 2023 Dec 21;13(1):45. doi: 10.3390/jcm13010045.
严重度的呼吸衰竭和计算机胸部断层扫描在急性 COVID-19 中与感染 SARS-CoV-2 后的肺功能和呼吸症状相关:一项长达 12 个月的观察性纵向研究。
Respir Med. 2022 Jan;191:106709. doi: 10.1016/j.rmed.2021.106709. Epub 2021 Dec 1.
4
Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy.根据肺段解剖结构分析2019冠状病毒病相关急性呼吸窘迫综合征后高分辨率CT表现的间质性肺疾病
J Clin Med. 2021 Sep 2;10(17):3985. doi: 10.3390/jcm10173985.
5
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.COVID-19 住院幸存者 1 年结局:一项纵向队列研究。
Lancet. 2021 Aug 28;398(10302):747-758. doi: 10.1016/S0140-6736(21)01755-4.
6
COVID-19 and the effects on pulmonary function following infection: A retrospective analysis.新型冠状病毒肺炎及其感染后对肺功能的影响:一项回顾性分析。
EClinicalMedicine. 2021 Sep;39:101079. doi: 10.1016/j.eclinm.2021.101079. Epub 2021 Aug 13.
7
COVID-19: breaking down a global health crisis.COVID-19:破解一场全球健康危机。
Ann Clin Microbiol Antimicrob. 2021 May 18;20(1):35. doi: 10.1186/s12941-021-00438-7.
8
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.COVID-19 相关住院患者的 3 个月、6 个月、9 个月和 12 个月呼吸结局:一项前瞻性研究。
Lancet Respir Med. 2021 Jul;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0. Epub 2021 May 5.
9
A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study.中度和高度心血管疾病风险人群中相似的终生心血管风险和相似的心脏代谢特征:一项基于人群的研究。
J Clin Med. 2021 Apr 9;10(8):1584. doi: 10.3390/jcm10081584.
10
Severe covid-19 pneumonia: pathogenesis and clinical management.严重 COVID-19 肺炎:发病机制与临床管理。
BMJ. 2021 Mar 10;372:n436. doi: 10.1136/bmj.n436.